0001843212December 31false2022Q3P10D.2500018432122022-01-012022-09-300001843212kahc:OneShareOfClassACommonStockAndOneFourthOfOneRedeemableWarrantMember2022-01-012022-09-300001843212us-gaap:CommonClassAMember2022-01-012022-09-300001843212us-gaap:WarrantsAndRightsSubjectToMandatoryRedemptionMember2022-01-012022-09-300001843212us-gaap:CommonClassAMember2022-11-09xbrli:shares0001843212us-gaap:CommonClassBMember2022-11-0900018432122022-09-30iso4217:USD00018432122021-12-31iso4217:USDxbrli:shares0001843212us-gaap:CommonClassAMember2022-09-300001843212us-gaap:CommonClassAMember2021-12-310001843212us-gaap:CommonClassBMember2021-12-310001843212us-gaap:CommonClassBMember2022-09-3000018432122022-07-012022-09-3000018432122021-07-012021-09-3000018432122021-01-142021-09-300001843212us-gaap:CommonClassAMember2022-07-012022-09-300001843212us-gaap:CommonClassAMember2021-07-012021-09-300001843212us-gaap:CommonClassAMember2021-01-142021-09-300001843212us-gaap:CommonClassBMember2022-07-012022-09-300001843212us-gaap:CommonClassBMember2021-07-012021-09-300001843212us-gaap:CommonClassBMember2022-01-012022-09-300001843212us-gaap:CommonClassBMember2021-01-142021-09-300001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-310001843212us-gaap:AdditionalPaidInCapitalMember2021-12-310001843212us-gaap:RetainedEarningsMember2021-12-310001843212us-gaap:RetainedEarningsMember2022-01-012022-03-3100018432122022-01-012022-03-310001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-03-310001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-03-310001843212us-gaap:AdditionalPaidInCapitalMember2022-03-310001843212us-gaap:RetainedEarningsMember2022-03-3100018432122022-03-310001843212us-gaap:RetainedEarningsMember2022-04-012022-06-3000018432122022-04-012022-06-300001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-06-300001843212us-gaap:AdditionalPaidInCapitalMember2022-06-300001843212us-gaap:RetainedEarningsMember2022-06-3000018432122022-06-300001843212us-gaap:RetainedEarningsMember2022-07-012022-09-300001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-09-300001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-09-300001843212us-gaap:AdditionalPaidInCapitalMember2022-09-300001843212us-gaap:RetainedEarningsMember2022-09-300001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-130001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-130001843212us-gaap:AdditionalPaidInCapitalMember2021-01-130001843212us-gaap:RetainedEarningsMember2021-01-1300018432122021-01-130001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-142021-03-310001843212us-gaap:AdditionalPaidInCapitalMember2021-01-142021-03-3100018432122021-01-142021-03-310001843212us-gaap:RetainedEarningsMember2021-01-142021-03-310001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-310001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-03-310001843212us-gaap:AdditionalPaidInCapitalMember2021-03-310001843212us-gaap:RetainedEarningsMember2021-03-3100018432122021-03-310001843212us-gaap:RetainedEarningsMember2021-04-012021-06-3000018432122021-04-012021-06-300001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-06-300001843212us-gaap:AdditionalPaidInCapitalMember2021-06-300001843212us-gaap:RetainedEarningsMember2021-06-3000018432122021-06-300001843212us-gaap:RetainedEarningsMember2021-07-012021-09-300001843212us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-09-300001843212us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-09-300001843212us-gaap:AdditionalPaidInCapitalMember2021-09-300001843212us-gaap:RetainedEarningsMember2021-09-3000018432122021-09-300001843212us-gaap:IPOMember2021-03-192021-03-190001843212us-gaap:OverAllotmentOptionMember2021-03-192021-03-190001843212us-gaap:OverAllotmentOptionMember2021-03-1900018432122021-03-192021-03-1900018432122021-03-190001843212kahc:PrivatePlacementWarrantsMember2021-03-192021-03-190001843212kahc:PrivatePlacementWarrantsMember2021-03-190001843212us-gaap:IPOMember2021-03-190001843212srt:MinimumMember2021-03-192021-03-19kahc:businessxbrli:pure0001843212us-gaap:CommonClassAMember2021-03-190001843212srt:MaximumMember2021-03-190001843212kahc:PublicWarrantsMember2021-03-192021-03-190001843212us-gaap:CommonClassAMember2021-01-142021-12-3100018432122021-01-012021-09-300001843212kahc:PublicWarrantsMember2021-03-190001843212us-gaap:WarrantMember2021-03-190001843212us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-01-252021-01-250001843212us-gaap:CommonClassBMember2021-01-250001843212us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-03-162021-03-160001843212us-gaap:CommonClassBMember2021-03-160001843212srt:MaximumMemberus-gaap:InvestorMemberus-gaap:CommonClassBMember2021-03-160001843212us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-03-160001843212us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-03-190001843212us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-03-192021-03-190001843212srt:MinimumMemberus-gaap:CommonClassAMember2021-03-190001843212us-gaap:CommonClassAMember2021-03-192021-03-190001843212srt:MinimumMemberus-gaap:CommonClassAMember2021-03-192021-03-190001843212kahc:PromissoryNoteMemberus-gaap:InvestorMember2021-01-252021-01-250001843212kahc:PromissoryNoteMemberus-gaap:InvestorMember2021-03-192021-03-190001843212us-gaap:InvestorMemberkahc:AdvanceMember2021-03-192021-03-190001843212us-gaap:InvestorMemberkahc:PromissoryNoteAndAdvanceMember2021-03-222021-03-220001843212kahc:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMemberkahc:WorkingCapitalLoansMember2021-01-252021-01-250001843212kahc:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMemberkahc:WorkingCapitalLoansMember2021-01-250001843212kahc:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMemberkahc:WorkingCapitalLoansMember2022-09-300001843212kahc:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMemberkahc:WorkingCapitalLoansMember2021-12-310001843212kahc:ReimbursementOfOperatingExpensesMemberkahc:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember2022-09-300001843212kahc:ReimbursementOfOperatingExpensesMemberkahc:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember2021-12-310001843212kahc:KkrCapitalMarketsLlcMemberkahc:FinancialAdvisoryServicesFeeBasedOnUpfrontUnderwritingCommissionsPaidMember2021-03-192021-03-190001843212kahc:FinancialAdvisoryServicesFeeBasedOnDeferredUnderwritingCommissionsPaidMemberkahc:KkrCapitalMarketsLlcMember2021-03-192021-03-1900018432122021-03-16kahc:vote0001843212us-gaap:InvestorMemberus-gaap:CommonClassBMember2022-09-300001843212kahc:PublicWarrantsMember2021-12-310001843212kahc:PublicWarrantsMember2022-09-300001843212kahc:PrivatePlacementWarrantsMember2022-09-300001843212kahc:PrivatePlacementWarrantsMember2021-12-310001843212kahc:PublicWarrantsMember2021-01-140001843212us-gaap:CommonClassAMembersrt:MaximumMemberkahc:AdditionalOfferingMember2021-03-190001843212srt:MinimumMemberkahc:AdditionalOfferingMember2021-03-192021-03-190001843212us-gaap:CommonClassAMemberkahc:AdditionalOfferingMember2021-03-192021-03-190001843212kahc:AdditionalOfferingMember2021-03-192021-03-190001843212kahc:AdditionalOfferingMember2021-03-190001843212kahc:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember2021-03-192021-03-190001843212kahc:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember2021-03-192021-03-190001843212kahc:WarrantsAndRightsSubjectToMandatoryRedemptionOneMembersrt:MinimumMemberus-gaap:CommonClassAMember2021-03-190001843212kahc:WarrantsAndRightsSubjectToMandatoryRedemptionOneMember2021-03-190001843212srt:MinimumMemberus-gaap:CommonClassAMemberkahc:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember2021-03-190001843212kahc:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember2021-03-190001843212us-gaap:CommonClassAMemberkahc:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMember2021-03-192021-03-190001843212kahc:WarrantsAndRightsSubjectToMandatoryRedemptionTwoMembersrt:MaximumMember2021-03-190001843212us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212kahc:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel2Memberkahc:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212kahc:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel1Memberkahc:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel2Memberkahc:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel3Memberkahc:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001843212us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212kahc:PublicWarrantsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:FairValueInputsLevel2Memberkahc:PublicWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212kahc:PublicWarrantsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:FairValueInputsLevel1Memberkahc:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:FairValueInputsLevel2Memberkahc:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:FairValueInputsLevel3Memberkahc:PrivatePlacementWarrantsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001843212us-gaap:WarrantMemberus-gaap:MeasurementInputExpectedDividendRateMember2022-09-300001843212us-gaap:WarrantMemberus-gaap:MeasurementInputExercisePriceMember2022-09-300001843212us-gaap:WarrantMemberus-gaap:MeasurementInputExercisePriceMember2021-12-310001843212us-gaap:WarrantMemberus-gaap:MeasurementInputSharePriceMember2022-09-300001843212us-gaap:WarrantMemberus-gaap:MeasurementInputSharePriceMember2021-12-310001843212us-gaap:WarrantMember2022-09-300001843212us-gaap:WarrantMember2021-12-310001843212us-gaap:WarrantMemberus-gaap:MeasurementInputPriceVolatilityMember2022-09-300001843212us-gaap:WarrantMemberus-gaap:MeasurementInputPriceVolatilityMember2021-12-310001843212us-gaap:WarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2022-09-300001843212us-gaap:WarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2022-06-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2022-07-012022-09-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2022-09-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-12-310001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2022-01-012022-09-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-06-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-07-012021-09-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-09-300001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-01-130001843212us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-01-142021-09-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

KKR ACQUISITION HOLDINGS I CORP.

(Exact name of registrant as specified in its charter)


Delaware	001-40225	86-1506732
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

30 Hudson Yards, Suite 7500

New York, NY 10001

(Address of principal executive offices, including zip code)

(212) 750-8300

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange
on which registered

Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-fourth of one redeemable Warrant

KAHC.U

The New York Stock Exchange

Class A common stock, par value $0.0001 per share

KAHC

The New York Stock Exchange

Redeemable Warrants, each whole Warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share

KAHC WS

The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☐

Emerging growth company

☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ¨

As of November 9, 2022, 138,000,000 shares of Class A common stock, par value $0.0001 and subject to possible redemption, and 34,500,000 shares of Class B common stock, par value $0.0001, were issued and outstanding.

Table of Contents

KKR ACQUISITION HOLDINGS I CORP.

Quarterly Report on Form 10-Q

Table of Contents


		Page

PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021	1
	Condensed Statements of Operations for the three months ended September 30, 2022 and 2021, for the nine months ended September 30, 2022 and for the period from January 14, 2021 (inception) through September 30, 2021 (Unaudited)	2
	Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2022 and for the three months ended September 30, 2021 and for the period from January 14, 2021 (inception) through S eptember 30, 2021 (Unaudited)	3
	Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and for the period from January 14, 2021 (inception) through September 30, 2021 (Unaudited)	5
	Notes to Unaudited Condensed Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	26
Item 4.	Controls and Procedures	26
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities	27
Item 3.	Defaults Upon Senior Securities	27
Item 4.	Mine Safety Disclosures	27
Item 5.	Other Information	28
Item 6.	Exhibits	28
SIGNATURES		29

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

KKR ACQUISITION HOLDINGS I CORP.

CONDENSED BALANCE SHEET


	September 30, 2022		December 31, 2021
	(Unaudited)
Assets:
Current assets:
Cash	$	1,584,884	$	1,584,884
Prepaid expenses	682,231		1,483,466
Total current assets	2,267,115		3,068,350
Prepaid expenses, less current portion	—		247,243
Investments held in Trust Account	1,388,304,446		1,380,085,256
Total Assets	$	1,390,571,561	$	1,383,400,849

Liabilities, Redeemable Common Stock and Stockholders’ Deficit:
Current liabilities:
Accounts payable	$	1,019,116	$	185,092
Accrued expenses	2,997,307		618,719
Franchise tax payable	—		190,187
Due to related party	3,258,940		1,667,702
Total current liabilities	7,275,363		2,661,700
Derivative warrant liabilities	6,748,000		57,102,670
Deferred underwriting commissions	48,300,000		48,300,000
Total liabilities	62,323,363		108,064,370

Commitments and Contingencies

Class A common stock subject to possible redemption, 138,000,000 shares issued and outstanding and subject to possible redemption at $10.05 and $10.00 per share, respectively	1,386,282,832		1,380,000,000

Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	—		—
Class A common stock, $0.0001 par value; 500,000,000 shares authorized; no shares issued or outstanding (excluding 138,000,000 shares subject to possible redemption)	—		—
Class B common stock, $0.0001 par value; 50,000,000 shares authorized; 34,500,000 shares issued and outstanding	3,450		3,450
Additional paid-in capital	—		—
Accumulated deficit	(58,038,084)		(104,666,971)
Total stockholders’ deficit	(58,034,634)		(104,663,521)
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit	$	1,390,571,561	$	1,383,400,849

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

KKR ACQUISITION HOLDINGS I CORP.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)


	For the three Months Ended September 30, 2022		For the three Months Ended September 30, 2021		For the nine Months Ended September 30, 2022		For the Period from January 14, 2021 (Inception) through September 30, 2021

General and administrative expenses	$	1,603,751	$	727,267	$	3,830,714	$	1,645,721
Franchise tax expense	49,315		49,863		147,397		140,324
Loss from operations	(1,653,066)		(777,130)		(3,978,111)		(1,786,045)
Change in fair value of derivative warrant liabilities	13,496,000		13,023,330		50,354,670		10,211,670
Offering costs associated with derivative warrant liabilities	—		—		—		(2,189,290)
Income from investments held in Trust Account	6,178,898		19,480		8,219,190		60,528


Net income before taxes	$	18,021,832	$	12,265,680	$	54,595,749	$	6,296,863
Income tax expense	$	(1,021,524)	$	—	$	(1,684,030)	$	—
Net income	$	17,000,308	$	12,265,680	$	52,911,719	$	6,296,863

Basic and diluted weighted average shares outstanding of Class A common stock subject to possible redemption	138,000,000		138,000,000		138,000,000		104,030,769
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption	$	0.07	$	0.07	$	0.27	$	(0.79)
Basic and diluted weighted average shares outstanding of Class B common stock	34,500,000		34,500,000		34,500,000		31,882,692
Basic and diluted net income (loss) per share, Class B common stock	$	0.07	$	0.07	$	0.27	$	(0.79)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

KKR ACQUISITION HOLDINGS I CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT (UNAUDITED)


	Common Stock						Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit
	Class A			Class B
	Shares	Amount		Shares	Amount
Balance - January 1, 2022	—	$	—	34,500,000	$	3,450	$	—	$	(104,666,971)	$	(104,663,521)
Net Income									18,813,331		18,813,331
Balance - March 31, 2022	—	—		34,500,000	3,450		—		(85,853,640)		(85,850,190)
Subsequent measurement of Class A common stock Subject to Redemption under ASC 480-10-S99 against accumulated deficit									(1,174,773)		(1,174,773)
Net income	—	—		—	—		—		17,098,080		17,098,080
Balance - June 30, 2022	—	$	—	34,500,000	$	3,450	$	—	$	(69,930,333)	$	(69,926,883)
Subsequent measurement of Class A common stock Subject to Redemption under ASC 480-10-S99 against accumulated deficit									(5,108,059)		(5,108,059)
Net income									17,000,308		17,000,308
Balance - September 30, 2022	—	$	—	34,500,000	$	3,450	$	—	$	(58,038,084)	$	(58,034,634)

Table of Contents


	Common Stock						Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit
	Class A			Class B
	Shares	Amount		Shares	Amount
Balance - January 14, 2021 (Inception)	—	$	—	—	$	—	$	—	$	—	$	—
Issuance of Class B common stock to Sponsor	—	—		34,500,000	3,450		21,550		—		25,000
Excess of Fair Value Paid by Private Placement Warrant holders	—	—		—	—		6,737,330		—		6,737,330
Subsequent measurement of Class A common stock Subject to Redemption under ASC 480-10-S99 against additional paid-in capital	—	—		—	—		(6,758,880)		—		(6,758,880)
Subsequent measurement of Class A common stock Subject to Redemption under ASC 480-10-S99 against accumulated deficit	—	—		—	—		—		(107,396,898)		(107,396,898)
Net loss									(6,063,553)		(6,063,553)
Balance - March 31, 2021	—	—		34,500,000	3,450		—		(113,460,451)		(113,457,001)
Net income	—	—		—	—		—		94,736		94,736
Balance - June 30, 2021	—	$	—	34,500,000	$	3,450	$	—	$	(113,365,715)	$	(113,362,265)
Net Income									12,265,680		12,265,680
Balance - September 30, 2021	—	$	—	34,500,000	$	3,450	$	—	$	(101,100,035)	$	(101,096,585)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

KKR ACQUISITION HOLDINGS I CORP.

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)


	For the Nine Months Ended September 30, 2022		For the Period from January 14, 2021 (Inception) through September 30, 2021
Cash Flows from Operating Activities:
Net income	$	52,911,719	$	6,296,863
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	(50,354,670)		(10,211,670)
Offering costs associated with derivative warrant liabilities	—		2,189,290
Income from investments held in Trust Account	(8,219,190)		(60,528)
Changes in operating assets and liabilities:
Prepaid expenses	1,048,478		(2,101,576)
Accounts payable	834,024		92,863
Accrued expenses	2,378,588		41,417
Franchise tax payable	(190,187)		140,324
Due to related party	1,591,238		1,524,794
Net cash used in operating activities	—		(2,088,223)

Cash Flows from Investing Activities
Cash deposited in Trust Account	—		(1,380,000,000)
Net cash used in investing activities	—		(1,380,000,000)

Cash Flows from Financing Activities:
Repayment of note payable to related party	—		(449,513)
Proceeds from notes payable to related party	—		449,513
Proceeds received from initial public offering, gross	—		1,380,000,000
Proceeds from issuance of Class B common stock	—		25,000
Proceeds received from private placement warrants	—		32,600,000
Reimbursement from underwriters	—		13,800,000
Offering costs paid	—		(42,751,893)
Net cash provided by financing activities	—		1,383,673,107

Net change in cash	—		1,584,884

Cash - beginning of the period	1,584,884		—
Cash - end of the period	$	1,584,884	$	1,584,884

Supplemental disclosure of noncash activities:
Remeasurement of Class A common stock subject to possible redemption	$	6,282,832	$	114,155,778
Initial measurement of Public and Private Warrants	$	—	$	64,847,670
Deferred underwriting commissions in connection with the initial public offering	$	—	$	48,300,000

The accompanying notes are an integral part of these unaudited condensed financial statements.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

Note 1—Description of Organization and Business Operations

KKR Acquisition Holdings I Corp. (the “Company”) is a blank check company incorporated in Delaware on January 14, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of September 30, 2022, the Company had not commenced any operations. All activity for the period from January 14, 2021 (inception) through September 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) and identifying a target for an initial business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is KKR Acquisition Sponsor I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on March 16, 2021. On March 19, 2021, the Company consummated its Initial Public Offering of 138,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including the exercise of the underwriters’ option to purchase 18,000,000 additional Units (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $1.4 billion, and incurring offering costs of approximately $77.4 million (net of reimbursement from underwriters of $13.8 million), of which $48.3 million was for deferred underwriting commissions (Note 5).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 21,733,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $32.6 million (Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, approximately $1.4 billion ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete its initial Business Combination with one or more operating businesses or assets having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act.

The Company will provide the holders (the “Public Stockholders”) of the Company’s outstanding shares of Class A common stock, par value $0.0001 per share, included in the Units sold in the Initial Public Offering (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, subject to applicable law and stock exchange listing requirements. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

discussed in Note 5). All Public Shares have been recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination only if a majority of the shares voted are voted in favor of the Business Combination. The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 or any greater net tangible asset or cash requirement that may be contained in the agreement relating to the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the initial stockholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination or to not vote at all. In addition, the initial stockholders agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

The Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its Public Shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company.

The Sponsor and the Company’s officers and directors (the “initial stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to allow redemptions in connection with its initial Business Combination or redeem 100% of the Public Shares if the Company does not complete a Business Combination within the initial Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 19, 2023 (as such period may be extended by the Company’s stockholders in accordance with the Certificate of Incorporation, the “Combination Period”), the Company will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds in the Trust Account (net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The initial stockholders agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial stockholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value in the Trust Account will be only $10.00 or potentially less. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, Targets and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity, Capital Resources and Going Concern

As of September 30, 2022, the Company had investments held in the Trust Account of $1.4 billion consisting of cash and U.S. government securities. Interest income on the balance in the Trust Account may be used by the Company to pay taxes, and to pay up to $100,000 of any dissolution expenses. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Class B common stock, a loan from the Sponsor pursuant to the promissory note (see Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the promissory note during 2021.

As of September 30, 2022, the Company had current liabilities of $7.3 million and approximately $1.6 million in its operating bank account. The Company does not have sufficient liquidity to meet its anticipated obligations over the next year from the date of issuance of these financial statements. In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern,” management has determined that if the Company is unsuccessful in consummating an initial Business Combination, the mandatory liquidation and subsequent dissolution raises substantial doubt about the ability to continue as a going concern for at least one year from the issuance of the financial statements. The Company has access to funds from the Sponsor that are sufficient to fund the working capital needs of the Company until a potential business combination or up to the mandatory liquidation as stipulated in the certificate of incorporation. As of September 30, 2022, there were no amounts outstanding under any working capital loan (see Note 4). Management further intends to close a Business Combination before the mandatory liquidation date. In connection with the assessment of going concern considerations in accordance with the FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” the Company has determined that the working capital deficit, as well as the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and the invasion by Russia of Ukraine and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2—Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in Company's Annual Report on Form 10-K filed with the SEC on March 31, 2022.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it takes advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents held outside the Trust Account as of September 30, 2022 and as of December 31, 2021.

Investments Held in Trust Account

The Company’s portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the unaudited condensed balance sheet at fair value at the end of each reporting period. Gains and losses from changes in fair value, and dividends and interest relating to these investments are included in Income from investments held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At September 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the balance sheet.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

•Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 and FASB ASC Topic 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The 34,500,000 warrants issued in connection with the Initial Public Offering and exercise of the over-allotment (the “Public Warrants”) and the 21,733,333 Private Placement Warrants are recognized as derivative liabilities in accordance with FASB ASC Topic 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at the end of each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The estimated fair value of the Private Placement Warrants is measured at fair value using a Black-Scholes valuation model as of September 30, 2022 and December 31, 2021, while the Public Warrants were valued based on their quoted market price as of September 30, 2022 and December 31, 2021.

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering on a relative residual method, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock were charged to Class A common stock upon the completion of the Initial Public Offering.

Class A Common Stock Subject to Possible Redemption

The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A common stock subject to mandatory redemption (if any) is classified as a liability instrument and measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2022 and December 31, 2021, all 138,000,000 shares of Class A common stock subject

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s unaudited condensed balance sheet.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

As of September 30, 2022 and December 31, 2021, the Class A common stock reflected on the balance sheet are reconciled in the following table:


Gross Proceeds	$	1,380,000,000
Less:
Proceeds allocated to Public Warrants	(38,985,000)
Class A common stock issuance costs	(75,170,778)
Plus:
Accretion of carrying value to redemption value	114,155,778
Contingently redeemable Class A common stock as of December 31, 2021	$	1,380,000,000
Plus:
Accretion of carrying value to redemption value	6,282,832
Contingently redeemable Class A common stock as of September 30, 2022	$	1,386,282,832

Stock-Based Compensation Expense

The Company accounts for stock-based compensation expense in accordance with ASC 718, “Compensation - Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred.

The Company’s Class B common stock include a performance condition, namely the occurrence of a Business Combination. Compensation expense related to these shares is recognized only when the performance condition is probable of occurrence, or more specifically when a Business Combination is consummated. Therefore, no stock-based compensation expense has been recognized.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

For tax benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2022 and December 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes as of September 30, 2022 and 2021 differs from the amount that would be provided by applying the statutory U.S. federal income tax rate of 21% to

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

pre-tax income primarily due to the establishment of a full valuation allowance against the Company’s deferred tax asset. The Company’s effective tax rate differs from the federal statutory rate primarily due to the fair value on financial instruments treated as debt for GAAP and equity for tax purposes, which is not deductible or taxable for income tax purposes. As of September 30, 2022 the Company accrued $1,684,030 income tax payable, which are included within Accrued Expenses on the Condensed Balance Sheet. The effective tax rates were 5.7%, 3.1%, 0.0% and 0.0% for the three and nine months ended September 30, 2022 and 2021, respectively.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal (non-deductible) 1% excise tax on certain repurchases (including redemptions) of shares of stock by publicly traded “covered corporations.” For these purposes a “covered corporation” includes entities treated as U.S. corporations under the Internal Revenue Code (including as a result of the “inversion” rules) and in certain circumstances, U.S. subsidiaries of publicly traded non-U.S. corporations. The excise tax is imposed directly on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally equal to 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of determining the fair market value of the repurchased shares, a covered corporation is permitted to reduce the value of the repurchased shares by the fair market value of certain new stock issuances made in the same taxable year. In addition, there are a limited number of other exclusions that may apply to the excise tax. The U.S. Department of the Treasury has been given broad authority to provide regulations and other guidance to implement the excise tax and prevent the abuse or avoidance of the excise tax. The excise tax applies only to repurchases that occur after December 31, 2022.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with an initial business combination, our liquidation or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in respect of taxable years beginning after December 31, 2022 will depend on a number of factors, including (i) the fair market value of shares of our common stock that are redeemed or otherwise repurchased by us in the applicable tax year, (ii) the nature and amount of any “PIPE” or other equity issuances that occur in connection with the initial business combination (or otherwise issued not in connection with the initial business combination but issued within the same taxable year in which the initial business combination occurs), (iii) the structure of any initial business combination as it pertains to shares of the Company's common stock and (iv) the content of regulations and other guidance from the U.S. Department of the Treasury in respect of the excise tax and its implementation. The excise tax could cause a reduction in the cash available on hand to complete an initial business combination, could otherwise impact the Company's ability to complete an initial business combination and/or could negatively impact stockholders who exercise their redemption rights after December 31, 2022.

Net Income (Loss) Per Common Share

Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common stock outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase up to an aggregate of 56,233,333 shares of the Company’s Class A common stock in the calculation of the diluted income per share, because the warrants are contingently exercisable, and the contingencies have not yet been met. Similarly, for the purpose of calculating the diluted income (loss) per share for the Class A common stock, the Company has not considered the conversion of the Class B common stock, because the contingency for the conversion into Class A common stock was not met as of the reporting date.

The Company’s unaudited condensed statement of operations includes a presentation of income (loss) per common share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per common share. For purposes of calculating net income (loss) per share, the Company allocated the amount using a ratio reflective of the respective participation right and the weighted average of each class of common stock. The allocation for three and nine month ended September 30, 2022 and for the period from Inception through September 30, 2021 also considered the accretion of temporary equity related to the Class A common stock.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

The following table reflects the calculation of basic and diluted net income (loss) per common share:


	For the Three Months Ended September 30, 2022		For the Three Months Ended September 30, 2021
Class A common stock subject to possible redemption
Numerator: Earnings allocable to common stock subject to possible redemption
Allocation of net income, including accretion of temporary equity	$	9,513,799	$	9,812,544
Net income attributable to Class A common stock subject to redemption	$	9,513,799	$	9,812,544
Denominator: Weighted average Class A common stock subject to possible redemption
Basic and diluted weighted average shares outstanding	138,000,000		138,000,000
Basic and diluted net income per Class A shares	$	0.07	$	0.07

Class B common stock
Numerator: Earnings allocable to Class B common stock
Allocation of net income, including accretion of temporary equity	2,378,450		2,453,136
Net income attributable to Class B common stock	$	2,378,450	$	2,453,136
Denominator: weighted average Class B common stock
Basic and diluted weighted average shares outstanding, Class B common stock	34,500,000		34,500,000
Basic and diluted net income per share, Class B common stock	$	0.07	$	0.07

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)


	For the Nine Months Ended September 30, 2022		For the period from January 14, 2021 (inception) through September 30, 2021
Class A common stock subject to possible redemption
Numerator: Earnings (losses) allocable to common stock subject to possible redemption
Allocation of net income (loss), including accretion of temporary equity	$	37,303,110	$	(82,557,281)
Net income (loss) attributable to Class A common stock subject to redemption	$	37,303,110	$	(82,557,281)
Denominator: Weighted average Class A common stock subject to possible redemption
Basic and diluted weighted average shares outstanding	138,000,000		104,030,769
Basic and diluted net income (loss) per Class A shares	$	0.27	$	(0.79)

Class B common stock
Numerator: Earnings (losses) allocable to Class B common stock
Allocation of net income (loss), including accretion of temporary equity	9,325,777		(25,301,634)
Net income (loss) attributable to Class B common stock	$	9,325,777	$	(25,301,634)
Denominator: weighted average Class B common stock
Basic and diluted weighted average shares outstanding, Class B common stock	34,500,000		31,882,692
Basic and diluted net income (loss) per share, Class B common stock	$	0.27	$	(0.79)

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Note 3—Initial Public Offering

On March 19, 2021, the Company consummated its Initial Public Offering of 138,000,000 Units, including 18,000,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of approximately $1.4 billion, and incurring offering costs of approximately $77.4 million (net of reimbursement from underwriters of $13.8 million), of which $48.3 million was for deferred underwriting commissions and $0.1 million for other deferred financing costs.

Each Unit consists of one share of Class A common stock, and one-fourth of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

Note 4 — Related Party Transactions

Founder Shares

On January 25, 2021, the Sponsor paid $25,000 to cover certain offering costs on behalf of the Company in exchange for issuance of 28,750,000 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”). On March 16, 2021, the Company effected a stock dividend of 5,750,000 shares with respect to Class B common stock, resulting in an aggregate of 34,500,000 shares of Class B common stock outstanding. The Sponsor agreed to forfeit up to 4,500,000 Founder Shares to the extent that the option to purchase the Over-Allotment Units was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On March 19, 2021, the underwriter fully exercised its option to purchase the Over-Allotment Units; thus, these 4,500,000 Founder Shares were no longer subject to forfeiture.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (1) one year after the completion of the initial Business Combination; and (2) subsequent to the initial Business Combination (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20-trading days within any 30-trading day period commencing at least 120 days after the initial Business Combination or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 21,733,333 warrants Private Placement Warrants at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $32.6 million.

Each whole Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash (except in certain limited circumstances) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Loans

On January 25, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. As of March 19, 2021, the Sponsor had loaned $300,000 under the Note and advanced approximately $150,000 to the Company. The Company fully repaid the Note and the advance for a total of approximately $450,000 to the Sponsor on March 22, 2021.

In addition, in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lenders’ discretion, up to $3.0 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. The terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans. As of September 30, 2022 and December 31, 2021, the Company had a $3.3 million and $1.7 million payable outstanding to a related party of the Sponsor for the reimbursement of operating expenses incurred on behalf of the Company, respectively.

Financial Advisory Services

For financial advisory services provided by KKR Capital Markets LLC (“KCM”), a registered broker-dealer and a related party to the Sponsor in connection with the Initial Public Offering, the Company agreed to pay KCM a fee in an amount equal to (1) 50% of the upfront underwriting commissions payable to the underwriters, or $13.8 million, and (2) 50% of the deferred underwriting commissions payable to the underwriters, or approximately $24.2 million, which will be paid to KCM upon the closing of the initial Business Combination. The underwriters agreed to reimburse the Company for the fee to KCM as it becomes payable out of the underwriting commission.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

Note 5 — Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares), are entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 18,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. On March 19, 2021, the underwriters fully exercised their option to purchase additional Units.

The underwriters were entitled to an underwriting discount of $0.20 per Unit, or $27.6 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Unit, or $48.3 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

In addition, the underwriters reimbursed $13.8 million to the Company for fees payable to KCM as described in Note 4.

Note 6 — Stockholders’ Equity

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.

Class A Common Stock — The Company is authorized to issue 500,000,000 shares of Class A common stock with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were 138,000,000 shares of Class A common stock subject to possible redemption outstanding and classified as temporary equity.

Class B Common Stock — The Company is authorized to issue 50,000,000 shares of Class B common stock with a par value of $0.0001 per share. On January 25, 2021, the Company issued 28,750,000 shares of Class B common stock to the Sponsor. On March 16, 2021, the Company effected a stock dividend of 5,750,000 shares with respect to Class B common stock, resulting in an aggregate of 34,500,000 shares of Class B common stock outstanding. Of the 34,500,000 shares of Class B common stock outstanding, up to 4,500,000 shares of Class B common stock were subject to forfeiture, to the Company by the Sponsor for no consideration to the extent that the underwriters’ option to purchase the Over-Allotment Units was not exercised in full or in part, so that the number of shares of Class B common stock outstanding would collectively equal 20% of the Company’s issued and outstanding common stock after the Initial Public Offering. On March 19, 2021, the underwriters fully exercised their option to purchase the Over-Allotment Units; thus, these 4,500,000 shares of Class B common stock were no longer subject to forfeiture.

Holders of Class A common stock and holders of Class B common stock will vote together as a single class, with each share entitling the holder to one vote; provided, however that, prior to the closing of the Company’s initial Business Combination, only holders of Class B common stock will have the right to elect or remove the Company’s directors.

The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering, plus (ii) all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. Securities could be “deemed issued” for purposes of the conversion rate adjustment if such shares are issuable upon the conversion or exercise of convertible securities, warrants or similar securities.

Note 7 — Warrants

As of September 30, 2022 and December 31, 2021, the Company had 34,500,000 Public Warrants and 21,733,333 Private Placement Warrants outstanding.

Public Warrants may only be exercised in whole and only for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. If a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The warrants have an exercise price of $11.50 per share, subject to adjustment. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20-trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 and $10.00 per share redemption trigger prices described under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% and 100%, respectively, of the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants will be identical to the Public Warrants, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the Sponsor or its permitted transferees, except in certain limited circumstances. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):

•in whole and not in part;

•at a price of $0.01 per warrant;

•upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

•if, and only if, the last reported sale price of Class A common stock for any 20-trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like).

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period.

Except as described below, none of the Private Placement Warrants will be redeemable by us so long as they are held by the Sponsor or its permitted transferees.

Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants:

•in whole and not in part;

•at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A common stock;

•if, and only if, the Reference Value equals or exceeds $10.00 per share as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like; and

•if the Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above.

The “fair market value” of Class A common stock shall mean the volume-weighted average price of Class A common stock for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment).

If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

Note 8 — Fair Value Measurements

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.


Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Investments held in Trust Account - Money market funds	$	1,388,304,446	$	—	$	—

Liabilities:
Derivative warrant liabilities - Public warrants	$	4,140,000	$	—	$	—
Derivative warrant liabilities - Private placement warrants	$	—	$	—	$	2,608,000

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.


Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Assets:
Investments held in Trust Account - Money market funds	$	1,380,085,256	$	—	$	—

Liabilities:
Derivative warrant liabilities - Public warrants	$	34,500,000	$	—	$	—
Derivative warrant liabilities - Private placement warrants	$	—	$	—	$	22,602,670

The estimated fair value of the Private Placement Warrants is measured at fair value using a Black-Scholes valuation model as of September 30, 2022 and December 31, 2021, while the Public Warrants are based on their quoted market price as of September 30, 2022 and December 30, 2021. The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in option pricing and simulation models are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock assumption based on the implied volatility of the Public Warrants. The risk-free interest rate is based on the U.S. Treasury constant maturity rate on the issuance date for a maturity similar to the expected remaining life of the warrants.

The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:


	September 30, 2022			December 31, 2021
Exercise price	$	11.50		$	11.50
Class A common share value	$	9.84		$	9.74
Term	5			5
Volatility	1.0		%	17.8		%
Risk-free rate	4.06		%	1.59		%

The change in the fair value of Level 3 derivative warrant liabilities for the three and nine months ended September 30, 2022 is summarized as follows:


Level 3 - Derivative warrant liabilities at June 30, 2022	$	7,824,000
Change in fair value of derivative warrant liabilities	(5,216,000)
Level 3 - Derivative warrant liabilities at September 30, 2022	$	2,608,000

Unrealized gain on level 3 derivative warrant liabilities held at September 30, 2022	$	5,216,000

Level 3 - Derivative warrant liabilities at January 1, 2022	$	22,602,670
Change in fair value of derivative warrant liabilities	(19,994,670)
Level 3 - Derivative warrant liabilities at September 30, 2022	$	2,608,000

Unrealized gain on level 3 derivative warrant liabilities held at September 30, 2022	$	19,994,670

The change in the fair value of Level 3 derivative warrant liabilities for the three months ended September 30, 2021 and the period from January 14, 2021 (inception) through September 30, 2021 is summarized as follows:


Level 3 - Derivative warrant liabilities at June 30, 2021	$	26,949,330

Change in fair value of derivative warrant liabilities	(5,433,330)
Level 3 - Derivative warrant liabilities at September 30, 2021	$	21,516,000

Unrealized gain on level 3 derivative warrant liabilities held September 30, 2021	$	5,433,330

Level 3 - Derivative warrant liabilities at January 14, 2021 (inception)	$	—
Issuance of Public and Private Warrants	64,847,670
Transfer out of Public Warrants (change in levelling to Level 1)	(40,710,000)
Change in fair value of derivative warrant liabilities	(2,621,670)
Level 3 - Derivative warrant liabilities at September 30, 2021	$	21,516,000

Unrealized loss on level 3 derivative warrant liabilities held at September 30, 2021	$	4,346,670

Transfers to or from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the period for the three months and nine months ended September 30, 2022 and September 30, 2021 except for the transfer of the Public Warrants from Level III to Level I, which occurred in the second quarter of 2021.

KKR ACQUISITION HOLDINGS I CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

Note 9 — Subsequent Events

Management has evaluated subsequent events to determine if events or transactions occurring through the date the financial statements were issued require potential adjustment to or disclosure in the financial statements and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “our,” “us” or “we” refer to KKR Acquisition Holdings I Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in the Risk Factors section of our final prospectus for our Initial Public Offering (as defined below) and in our other Securities and Exchange Commission (“SEC”) filings. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in Delaware on January 14, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). We are an early-stage emerging growth company and, as such, subject to all of the risks associated with early stage and emerging growth companies. Our sponsor is KKR Acquisition Sponsor I LLC, a Delaware limited liability company (our “Sponsor”).

Our registration statement for our Initial Public Offering (the “Initial Public Offering”) became effective on March 16, 2021. On March 19, 2021, we consummated an Initial Public Offering of 138,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including the exercise of the underwriters’ option to purchase 18,000,000 additional Units (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $1.4 billion, and incurring offering costs of approximately $77.4 million (net of reimbursement from underwriters of $13.8 million), of which $48.3 million was for deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 21,733,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to our Sponsor, generating proceeds of $32.6 million.

Upon the closing of the Initial Public Offering and the Private Placement, approximately $1.4 billion ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 19, 2023 (as such period may be extended by our stockholders in accordance with the Certificate of Incorporation, the “Combination Period”), we will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds in the Trust Account (net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to

Table of Contents

receive further liquidating distributions, if any); and (3) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

On October 21, 2022, we filed a preliminary proxy statement in connection with a proposed special meeting of our stockholders to approve the extension of the date by which the Company has to consummate a business combination for an additional nine (9) months, from March 19, 2023 to December 19, 2023 (the “Extension”), as well as to permit our board of directors to elect to wind up our operations on an earlier date. This communication does not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval. Stockholders should read the definitive proxy statement, which will contain important information, and will be filed with the SEC (and available for free on the SEC’s website at http://www.sec.gov) and mailed to stockholders (if and when available).

Results of Operations

Our entire activity since inception through September 30, 2022 related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial Business Combination. We will generate non-operating income in the form of gain on investment (net), dividends and interest held in Trust Account. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses related to prospective business combination candidates. There can be no assurance that our plans to complete a Business Combination will be successful.

For the three months ended September 30, 2022 we had net income of approximately $17 million, which consisted of a loss from operations of approximately $1.7 million, a non-operating income of approximately $13.5 million for changes in fair value of derivative liabilities, and income from investments held in the Trust Account of approximately $6.2 million. The loss from operations consisted of approximately $1.6 million of general and administrative expenses and approximately $50,000 in franchise tax expense. We have also accrued income tax expense of approximately $1 million.

For the three months ended September 30, 2021, we had net income of approximately $12.3 million, which consisted of a loss from operations of approximately $777,130, a non-operating income of approximately $13.0 million for changes in fair value of derivative liabilities, and income from investments held in the Trust Account of approximately $19,000. The loss from operations consisted of approximately $727,000 of general and administrative expenses and approximately $50,000 in franchise tax expense.

For the nine months ended September 30, 2022 we had net income of approximately $52.9 million, which consisted of a loss from operations of approximately $4 million, a non-operating income of approximately $50.4 million for changes in fair value of derivative liabilities, and income from investments held in the Trust Account of approximately $8.2 million. The loss from operations consisted of approximately $3.9 million of general and administrative expenses and approximately $150,000 in franchise tax expense. We have also accrued income tax expense of approximately $1.7 million.

For the period from January 14, 2021 (inception) through September 30, 2021, we had net income of approximately $6.3 million, which consisted of a loss from operations of approximately $1.8 million, a non-operating expense of approximately $2.2 million for offering costs associated with derivative warrant liabilities, a non-operating income of approximately $10.2 million for changes in fair value of derivative liabilities, and income from investments held in the Trust Account of approximately $60,000. The loss from operations consisted of approximately $1.6 million of general and administrative expenses and approximately $140,000 in franchise tax expense.

Liquidity, Capital Resources and Going Concern

Prior to the completion of the Initial Public Offering, our liquidity needs were satisfied through expenses totaling $25,000 being paid by our Sponsor in exchange for issuance of 28,750,000 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”) to our Sponsor, the proceeds of a promissory note (the “Note”) from the Sponsor in the amount of $300,000 and an advancement of approximately $150,000. We fully repaid the Note and the advance for a total of approximately $450,000 to the Sponsor on March 22, 2021. We have since completed our Initial Public Offering at which time capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses was released to us for general working capital purposes.

Table of Contents

As of September 30, 2022, we had current liabilities of $7.3 million and approximately $1.6 million in our operating bank account. We do not have sufficient liquidity to meet our anticipated obligations over the next year from the date of issuance of the financial statements included in this report. In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern,” our management has determined that if the Company is unsuccessful in consummating an initial business combination, the mandatory liquidation and subsequent dissolution raise substantial doubt about our ability to continue as a going concern. We have access to funds from our Sponsor that are sufficient to fund the working capital needs of the Company until a potential business combination or up to the mandatory liquidation date as stipulated in the certificate of incorporation. As of September 30, 2022, there were no amounts outstanding under any working capital loan (see Note 4 to our unaudited condensed financial statements contained elsewhere in this Quarterly Report on Form 10-Q). As of September 30, 2022, we had a $3.3 million payable outstanding to a related party of our Sponsor for the reimbursement of operating expenses incurred on behalf of the Company. Management further intends to close an initial business combination before the mandatory liquidation date. In connection with our assessment of going concern considerations in accordance with the FASB ASC Topic 205-40, “Presentation of Financial Statements - Going Concern,” the Company has determined that the working capital deficit, as well as the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern.

We continue to evaluate the impact of the COVID-19 pandemic and Russia-Ukraine conflict and have concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities, other than a contingent obligation to pay the underwriters to our Initial Public Offering $48.3 million in the aggregate for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies

This management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. For a discussion of the company’s critical accounting policies, see Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K filed March 31, 2022. There have been no significant changes to our critical accounting estimates since our Annual Report on Form 10-K.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Off-Balance Sheet Arrangements

As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Inflation

We do not believe that inflation had a material impact on our business, revenues or operating results during the period presented.

Table of Contents

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, as an “emerging growth company,” we choose to rely on such exemptions and are not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act. Due to the short-term nature of these investments, we believe that there will be no associated material exposure to interest rate risk.

Item 4. Controls and Procedures

General

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial and accounting officer, to allow timely decisions regarding required disclosure.

Previously Disclosed Restatement and Material Weakness

As disclosed in Part I, “Item 1A. Risk Factors” of our Annual Report on Form 10-K, we previously identified a material weakness in our internal control over financial reporting related to the classification of our Class A common stock and related restatement of the Company's previous financial statements to classify all Class A common stock as temporary equity and to recognize accretion from the initial book value to redemption value at the time of the Company's Initial Public Offering and in accordance with ASC 480, as discussed in Note 9 to the interim financial statements included in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 (the “Restatement”).

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2022, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer concluded that during the period covered by this Quarterly Report on Form 10-Q and solely due to the events that led to the Restatement, our disclosure controls and procedures were not effective because of the material weakness in our internal control over financial reporting.

Remediation of Material Weakness in Internal Control Over Financial Reporting

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, the Company’s management has concluded that our control around the interpretation and accounting for certain complex features of the Class A common stock issued by the Company was not effectively designed or maintained. This material weakness resulted in the Restatement of the Company’s financial statements as described above.

In response to this material weakness, we have evaluated what actions to take to further enhance our processes to identify and appropriately apply applicable accounting requirements in the preparation of our financial statements, which are still in progress. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we are improving these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards. We continue to make progress in having increased communication and involvement among our personnel, our Sponsor and third-party professionals with whom we consult and depend upon regarding the application of complex accounting standards. The elements of our plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Table of Contents

Changes in Internal Control over Financial Reporting

Other than as set forth above, there was no change in our internal control over financial reporting that occurred during the quarter ended September 30, 2022 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors.

Except as set forth below, there have been no material changes with respect to those risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.

The excise tax included in the Inflation Reduction Act of 2022 may hinder our ability to consummate an initial business combination and/or decrease the amount of funds available for distribution in connection with a redemption or liquidation.

If the deadline for us to complete an initial business combination (currently March 19, 2023) is extended, our public stockholders will have the right to require us to redeem their Public Shares. Because any redemption that occurs as a result of the Extension would occur before December 31, 2022, we would not be subject to the excise tax as a result of any redemptions in connection with the Extension. However, any redemption or other repurchase that occurs after December 31, 2022, in connection with an initial business combination, our liquidation or otherwise, may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in respect of taxable years beginning after December 31, 2022 will depend on a number of factors, including (i) the fair market value of shares of our stock that are redeemed or otherwise repurchased by us in the applicable tax year, (ii) the nature and amount of any “PIPE” or other equity issuances that occur in connection with the initial business combination (or otherwise issued not in connection with the initial business combination but issued within the same taxable year in which the initial business combination occurs), (iii) the structure of any initial business combination as it pertains to shares of our stock and (iv) the content of regulations and other guidance from the U.S. Department of the Treasury in respect of the excise tax and its implementation. The excise tax could cause a reduction in the cash available on hand to complete an initial business combination, could otherwise impact our ability to complete an initial business combination and/or could negatively impact stockholders who exercise their redemption rights after December 31, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Table of Contents

Item 5. Other Information

None.

Item 6. Exhibits.


Exhibit Number			Description
31.1*			Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**			Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*			XBRL Instance Document

101.SCH*			XBRL Taxonomy Extension Schema Document

101.CAL*			XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*			XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*			XBRL Taxonomy Extension Label Linkbase Document

101.PRE*			XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith

** Furnished herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


	KKR ACQUISITION HOLDINGS I CORP.

Date: November 10, 2022	By:	/s/ Glenn Murphy
		Glenn Murphy
		Chief Executive Officer, Executive Chairman and Director

KKR Acquisition Holdings I Corp. 10-Q